Regulatory agencies such as the FDA and the EFSA have conducted comprehensive reviews of rebaudioside A. Both agencies have determined that it is safe for human consumption within the established Acceptable Daily Intake (ADI) levels. The ADI for rebaudioside A is set at 4 mg/kg body weight per day, based on rigorous safety assessments.
